Dolutegravir
Dolutegravir
Dolutegravir (pronounced doh-loo-TEG-ra-veer) is an antiretroviral medication used to treat and prevent HIV/AIDS. It is usually prescribed as part of combination therapy.
Etymology
The name "Dolutegravir" is derived from its chemical structure. The "Dolu" part of the name is a contraction of "2,4-difluorophenyl", which is a component of the drug's structure. The "tegravir" part of the name is a common suffix for integrase inhibitors, which is the class of drugs that Dolutegravir belongs to.
Usage
Dolutegravir is used in combination with other antiretroviral drugs to treat HIV. It works by inhibiting the enzyme integrase, which is necessary for the virus to replicate in the body. By blocking this enzyme, Dolutegravir prevents the virus from multiplying, which helps to control the infection.
Related Terms
- Antiretroviral therapy: The use of drugs to treat HIV.
- Integrase inhibitors: A class of drugs that block the enzyme integrase, which is necessary for HIV to replicate.
- HIV/AIDS: A disease caused by the human immunodeficiency virus.
Side Effects
Like all medications, Dolutegravir can cause side effects. Common side effects include nausea, headache, and diarrhea. More serious side effects can include liver damage and severe skin reactions.
Precautions
Before starting Dolutegravir, patients should inform their doctor if they have any allergies, liver disease, or if they are pregnant or planning to become pregnant. Dolutegravir can interact with other medications, so it's important to tell your doctor about all the medications you are currently taking.
External links
- Medical encyclopedia article on Dolutegravir
- Wikipedia's article - Dolutegravir
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski